Correlation between 6-mercaptopurine (6-MP) pharmacokinetic, blood lymphocyte subpopulations and clinical response to azathioprine (AZA) in Crohn's disease (CD).

被引：0
|
作者：
Cattan, S
Lemann, M
Thullier, F
Rabian, C
Ngo, Y
Bengoufa, D
Messing, B
Rambaud, JC
Modigliani, R
机构：
[1] ST LOUIS UNIV HOSP, PARIS, FRANCE
[2] HOP ST LAZARE, PARIS, FRANCE
来源：
GASTROENTEROLOGY | 1996年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A880 / A880
页数：1
相关论文
共 50 条
  • [1] Treatment of Crohn's disease (CD) with 6-mercaptopurine (6-MP) in patients intolerant to azathioprine (AZA).
    Lemann, M
    Bouhnik, Y
    Corguille, MKL
    Bonnet, J
    Coffin, B
    Marteau, P
    Bitoun, A
    Messing, B
    Jian, R
    Matuchansky, C
    Modigliani, R
    Rambaud, JC
    GASTROENTEROLOGY, 1997, 112 (04) : A1025 - A1025
  • [2] Azathioprine/6-mercaptopurine (AZA/6-MP) reduces the risk of intestinal re-operation in Crohn's Disease(CD)
    Papay, Pavol
    Ho, Elien
    Reinisch, Walter
    Miehsler, Wolfgang
    Vogelsang, Harald
    Novacek, Gottfried
    GASTROENTEROLOGY, 2007, 132 (04) : A52 - A52
  • [3] Safety and efficacy of azathioprine (AZA) and 6-mercaptopurine (6-MP) in the treatment of children and adolescents with Crohn's disease (CD) and ulcerative colitis (UC).
    Kirschner, BS
    GASTROENTEROLOGY, 1998, 114 (04) : A1010 - A1010
  • [4] 6-mercaptopurine pharmacokinetics and blood lymphocyte subpopulations in patients with Crohn's disease treated with azathioprine
    Cattan, S
    Lemann, M
    Thuillier, F
    Bengoufa, D
    Rabian, C
    Ngo, Y
    Bouhnik, Y
    Messing, B
    Rambaud, JC
    Modigliani, R
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1998, 22 (02): : 160 - 167
  • [5] Hepatotoxicity of 6-mercaptopurine (6-MP) and azathioprine (AZA) in adult IBD patients
    Shaye, Omid A.
    Yadegari, Michael
    Abreu, Maria T.
    Poordad, Fred
    Simon, Karen
    Martin, Paul
    Papadakis, Konstantinos A.
    Ippoliti, Andrew
    Vasiliauskas, Eric
    Tran, Tram T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (11): : 2488 - 2494
  • [6] Open prospective study on 6-thioguanine (6-TG) for Crohn's disease (CD) intolerant or resistant to azathioprine (AZA) and/or 6-mercaptopurine (6-MP)
    Harrer, M
    Schwab, M
    Teml, A
    Dejaco, C
    Mantl, M
    Vogelsang, H
    Reinisch, W
    GASTROENTEROLOGY, 2003, 124 (04) : A521 - A521
  • [7] Maintenance therapy with azathioprine (AZA)/6-mercaptopurine (6-MP) in Crohn's Disease (CD) reduces the risk of re-operation particularly in smokers
    Papay, Pavel
    Reinisch, Walter
    Ho, Elien
    Grauer, Cornelia
    Lissner, Donata
    Miehsler, Wolfgang
    Dejaco, Clemens
    Vogelsang, Harald
    Novacek, Gottfried
    GASTROENTEROLOGY, 2008, 134 (04) : A640 - A640
  • [8] PHARMACOKINETICS OF AZATHIOPRINE (AZA) AND 6-MERCAPTOPURINE (6-MP) AFTER ORAL-ADMINISTRATION OF AZA
    SALEMANS, J
    HOITSMA, A
    DEABREU, R
    DEVOS, D
    KIDNEY INTERNATIONAL, 1987, 31 (04) : 1047 - 1047
  • [9] Is the dosage of red blood cell 6-thioguanine concentration (RBC 6-TGN) useful in the management of Crohn's disease (Cd) treated with azathioprine (AZA) and 6-mercaptopurine (6-MP)?
    Belaiche, J
    Desager, JP
    Horsmans, Y
    Louis, E
    GASTROENTEROLOGY, 2000, 118 (04) : A784 - A784
  • [10] 6-mercaptopurine (6-MP): Does it increase or decrease the risks of colon cancer in Crohn's disease (CD)?
    Goldstein, ES
    Marion, JF
    Wheeler, S
    Present, DH
    GASTROENTEROLOGY, 1998, 114 (04) : A986 - A986
12345